Elisa Magrin

2.6k total citations
21 papers, 495 citations indexed

About

Elisa Magrin is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Elisa Magrin has authored 21 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Molecular Biology and 9 papers in Hematology. Recurrent topics in Elisa Magrin's work include Hemoglobinopathies and Related Disorders (9 papers), Prenatal Screening and Diagnostics (5 papers) and CRISPR and Genetic Engineering (5 papers). Elisa Magrin is often cited by papers focused on Hemoglobinopathies and Related Disorders (9 papers), Prenatal Screening and Diagnostics (5 papers) and CRISPR and Genetic Engineering (5 papers). Elisa Magrin collaborates with scholars based in France, Italy and United States. Elisa Magrin's co-authors include Marina Cavazzana, Annarita Miccio, Fulvio Mavilio, Leslie Weber, Chiara Antoniani, Tristan Félix, Vasco Meneghini, Yasuhiro Ikawa, Ante S. Lundberg and Matthew H. Porteus and has published in prestigious journals such as Blood, Biochemical Journal and Human Molecular Genetics.

In The Last Decade

Elisa Magrin

21 papers receiving 489 citations

Peers

Elisa Magrin
Megan D. Hoban United States
Chutima Kumkhaek United States
Miles United Kingdom
Liesbeth van Emst Netherlands
Ching Hon Pui United States
Raouf Alami United States
Megan D. Hoban United States
Elisa Magrin
Citations per year, relative to Elisa Magrin Elisa Magrin (= 1×) peers Megan D. Hoban

Countries citing papers authored by Elisa Magrin

Since Specialization
Citations

This map shows the geographic impact of Elisa Magrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Magrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Magrin more than expected).

Fields of papers citing papers by Elisa Magrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Magrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Magrin. The network helps show where Elisa Magrin may publish in the future.

Co-authorship network of co-authors of Elisa Magrin

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Magrin. A scholar is included among the top collaborators of Elisa Magrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Magrin. Elisa Magrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Magrin, Elisa, et al.. (2023). Sickle Cell Disease: From Genetics to Curative Approaches. Annual Review of Genomics and Human Genetics. 24(1). 255–275. 13 indexed citations
2.
Diana, Jean‐Sébastien, Naïm Bouazza, Martin Castelle, et al.. (2022). Bayesian Modeling Immune Reconstitution Apply to CD34+ Selected Stem Cell Transplantation for Severe Combined Immunodeficiency. Frontiers in Pediatrics. 9. 804912–804912. 1 indexed citations
3.
Diana, Jean‐Sébastien, Sandra Manceau, Thierry Leblanc, et al.. (2021). A new step in understanding stem cell mobilization in patients with Fanconi anemia: A bridge to gene therapy. Transfusion. 62(1). 165–172. 4 indexed citations
4.
Chalumeau, Anne, Giacomo Frati, Elisa Magrin, & Annarita Miccio. (2021). Reverse Phase-high-performance Liquid Chromatography (RP-HPLC) Analysis of Globin Chains from Human Erythroid Cells. BIO-PROTOCOL. 11(2). e3899–e3899. 5 indexed citations
5.
Manceau, Sandra, Jean‐Sébastien Diana, Laure Joseph, et al.. (2020). Vascular access for optimal hematopoietic stem cell collection. Journal of Clinical Apheresis. 36(1). 12–19. 9 indexed citations
6.
Magnani, Alessandra, Corinne Pondarré, Naïm Bouazza, et al.. (2019). Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy. Haematologica. 105(5). 1240–1247. 21 indexed citations
7.
André‐Schmutz, Isabelle, Laura Simons, Jean‐Sébastien Diana, et al.. (2019). Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy. Bone Marrow Transplantation. 54(S2). 749–755. 6 indexed citations
8.
Schmitt, Caroline, Louise Galmiche, Dominique Debray, et al.. (2019). Bone Marrow Transplantation in Congenital Erythropoietic Porphyria: Sustained Efficacy but Unexpected Liver Dysfunction. Biology of Blood and Marrow Transplantation. 26(4). 704–711. 9 indexed citations
9.
Ghardallou, M. El, Pierre Taupin, Fabien Touzot, et al.. (2019). Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation. Human Gene Therapy. 30(6). 753–761. 39 indexed citations
10.
Ikawa, Yasuhiro, Annarita Miccio, Elisa Magrin, et al.. (2019). Gene therapy of hemoglobinopathies: progress and future challenges. Human Molecular Genetics. 28(R1). R24–R30. 48 indexed citations
11.
Diana, Jean‐Sébastien, Sandra Manceau, Thierry Leblanc, et al.. (2019). A New Step in Understanding of Fanconi Patients Peripheral Stem Cell Harvesting, a Bridge to Gene Therapy. Blood. 134(Supplement_1). 1970–1970. 1 indexed citations
12.
Antoniani, Chiara, Vasco Meneghini, Annalisa Lattanzi, et al.. (2018). Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus. Blood. 131(17). 1960–1973. 145 indexed citations
13.
Weber, Leslie, Valentina Poletti, Elisa Magrin, et al.. (2018). An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype. Molecular Therapy — Methods & Clinical Development. 10. 268–280. 25 indexed citations
14.
Hebert, Nicolas, Elisa Magrin, Annarita Miccio, et al.. (2018). Analysis of RBC Properties in Patients with SCD Treated with Lentiglobin Gene Therapy. Blood. 132(Supplement 1). 2195–2195. 3 indexed citations
15.
Lovisa, Federica, Marco Zecca, Elisa Magrin, et al.. (2018). Pre‐ and post‐transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia. British Journal of Haematology. 180(5). 680–693. 42 indexed citations
16.
Paganin, Maddalena, Barbara Buldini, Giuseppe Germanò, et al.. (2016). A Case of T‐cell Acute Lymphoblastic Leukemia Relapsed As Myeloid Acute Leukemia. Pediatric Blood & Cancer. 63(9). 1660–1663. 7 indexed citations
17.
Antoniani, Chiara, Vasco Meneghini, Annalisa Lattanzi, et al.. (2016). Induction of Fetal Hemoglobin Synthesis By Crispr/Cas9-Mediated Disruption of the β-Globin Locus Architecture. Blood. 128(22). 321–321. 1 indexed citations
18.
Tibaldi, Elena, Francesca Zonta, Luciana Bordin, et al.. (2013). The tyrosine phosphatase SHP-1 inhibits proliferation of activated hepatic stellate cells by impairing PDGF receptor signaling. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(2). 288–298. 17 indexed citations
19.
Tibaldi, Elena, Andrea Venerando, Francesca Zonta, et al.. (2011). Interaction between the SH3 domain of Src family kinases and the proline-rich motif of HTLV-1 p13: a novel mechanism underlying delivery of Src family kinases to mitochondria. Biochemical Journal. 439(3). 505–518. 18 indexed citations
20.
Randi, Maria Luigia, Anna Maria Brunati, Margherita Scapin, et al.. (2009). Src tyrosine kinase preactivation is associated with platelet hypersensitivity in essential thrombocythemia and polycythemia vera. Blood. 115(3). 667–676. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026